Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.58B Sell
38,244,137
-720,234
-2% -$48M 0.04% 371
2026
Q1
$2.45B Sell
38,964,371
-884,006
-2% -$61.6M 0.04% 356
2025
Q4
$2.64B Buy
39,848,377
+1,026,534
+3% +$66.4M 0.04% 325
2025
Q3
$2.61B Sell
38,821,843
-210,253
-0.5% -$16.6M 0.05% 324
2025
Q2
$3.41B Sell
39,032,096
-209,081
-0.5% -$16.4M 0.06% 262
2025
Q1
$2.68B Sell
39,241,177
-358,424
-0.9% -$29.2M 0.06% 294
2024
Q4
$3.08B Buy
39,599,601
+4,574,990
+13% +$339M 0.06% 272
2024
Q3
$2.35B Buy
35,024,611
+505,246
+1% +$41.5M 0.05% 337
2024
Q2
$3.91B Buy
34,519,365
+596,713
+2% +$75.4M 0.09% 190
2024
Q1
$4.71B Buy
33,922,652
+1,196,466
+4% +$150M 0.11% 161
2023
Q4
$4.06B Sell
32,726,186
-16,643
-0.1% -$1.7M 0.1% 167
2023
Q3
$3.05B Sell
32,742,829
-512,124
-2% -$57.7M 0.09% 213
2023
Q2
$4.27B Sell
33,254,953
-11,383
-0% -$1.38M 0.12% 144
2023
Q1
$3.86B Buy
33,266,336
+76,443
+0.2% +$8.56M 0.11% 152
2022
Q4
$3.76B Sell
33,189,893
-420,068
-1% -$46.1M 0.12% 168
2022
Q3
$2.71B Buy
33,609,961
+175,464
+0.5% +$14.9M 0.09% 216
2022
Q2
$2.49B Sell
33,434,497
-314,823
-0.9% -$28.7M 0.08% 239
2022
Q1
$4.32B Buy
33,749,320
+1,235,504
+4% +$135M 0.12% 155
2021
Q4
$4.36B Buy
32,513,816
+2,000,896
+7% +$288M 0.11% 158
2021
Q3
$4.17B Sell
30,512,920
-574,268
-2% -$72.4M 0.12% 145
2021
Q2
$3.32B Buy
31,087,188
+1,698,492
+6% +$163M 0.09% 192
2021
Q1
$2.64B Buy
29,388,696
+1,355,404
+5% +$127M 0.08% 244
2020
Q4
$2.59B Sell
28,033,292
-1,021,116
-4% -$91.2M 0.08% 229
2020
Q3
$2.99B Buy
29,054,408
+656,456
+2% +$68.6M 0.11% 160
2020
Q2
$2.88B Buy
28,397,952
+4,591,360
+19% +$411M 0.11% 153
2020
Q1
$1.6B Buy
23,806,592
+1,813,972
+8% +$113M 0.08% 235
2019
Q4
$1.2B Buy
21,992,620
+767,656
+4% +$36.4M 0.05% 394
2019
Q3
$792M Sell
21,224,964
-26,824
-0.1% -$1.04M 0.03% 512
2019
Q2
$796M Buy
21,251,788
+261,560
+1% +$8.22M 0.03% 516
2019
Q1
$625M Buy
20,990,228
+646,644
+3% +$22.7M 0.03% 612
2018
Q4
$609M Buy
20,343,584
+3,695,912
+22% +$117M 0.03% 551
2018
Q3
$595M Buy
16,647,672
+181,988
+1% +$5.64M 0.03% 662
2018
Q2
$391M Buy
16,465,684
+915,732
+6% +$19.4M 0.02% 920
2018
Q1
$288M Buy
15,549,952
+351,892
+2% +$5.2M 0.01% 1094
2017
Q4
$218M Sell
15,198,060
-1,961,000
-11% -$25.5M 0.01% 1309
2017
Q3
$210M Sell
17,159,060
-406,556
-2% -$7.19M 0.01% 1303
2017
Q2
$321M Buy
17,565,616
+922,168
+6% +$17M 0.02% 938
2017
Q1
$353M Buy
16,643,448
+16,317,132
+5,000% +$318M 0.02% 855
2016
Q4
$4.87M Buy
326,316
+267,772
+457% +$4.74M 0.01% 935
2016
Q3
$1.28M Buy
58,544
+14,984
+34% +$333K ﹤0.01% 1392
2016
Q2
$864K Buy
43,560
+6,276
+17% +$107K ﹤0.01% 1486
2016
Q1
$633K Buy
37,284
+28,288
+314% +$473K ﹤0.01% 1496
2015
Q4
$184K Sell
8,996
-205,680
-96% -$4.28M ﹤0.01% 1668
2015
Q3
$4.61M Sell
214,676
-112,456
-34% -$2.51M 0.01% 810
2015
Q2
$6.54M Sell
327,132
-292
-0.1% -$5.13K 0.01% 769
2015
Q1
$5.1M Buy
327,424
+25,200
+8% +$381K 0.01% 837
2014
Q4
$4.16M Buy
302,224
+2,800
+0.9% +$34.3K 0.01% 871
2014
Q3
$2.99M Buy
299,424
+43,600
+17% +$446K ﹤0.01% 965
2014
Q2
$2.54M Buy
255,824
+247,104
+2,834% +$2.19M ﹤0.01% 996
2014
Q1
$90K Hold
8,720
﹤0.01% 1747
2013
Q4
$78K Sell
8,720
-188
-2% -$1.49K ﹤0.01% 1806
2013
Q3
$62K Hold
8,908
﹤0.01% 1772
2013
Q2
$50K Buy
+8,908
New +$42.7K ﹤0.01% 1858

Other funds holding DXCM

BlackRock's DXCM Position: Q2 2026 in Review

BlackRock reduced its DexCom (DXCM) stake by 1.8% in Q2 2026, selling an estimated $48M and leaving 38,244,137 shares worth $2.58B. The position accounts for 0.04% of the portfolio, ranked #371.

BlackRock first reported a position in DXCM in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.71B in Q1 2024. 758 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • BlackRock held 38,244,137 shares of DexCom worth $2.58B as of Q2 2026.
  • BlackRock sold 720,234 DexCom shares in Q2 2026, an estimated $48M.
  • DexCom made up 0.04% of BlackRock's portfolio in Q2 2026, its #371 holding.
  • BlackRock first reported a position in DexCom in Q2 2013 and has held it in 53 quarters since.
  • BlackRock's DexCom position peaked at $4.71B in Q1 2024.
  • 758 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.